Park Square has placed William Hodder as Chief Executive Officer at NFlection Therapeutics, Inc.
{
NFlection Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for rare RASopathies, today announced that it has appointed William Hodder as CEO.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
